Marathon Trading Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.1K Buy
+200
New +$23.1K ﹤0.01% 250
2025
Q2
Sell
-3,600
Closed -$323K 337
2025
Q1
$323K Buy
3,600
+2,300
+177% +$215K 0.04% 177
2024
Q4
$129K Buy
+1,300
New +$134K 0.01% 238
2024
Q1
Sell
-1,900
Closed -$207K 439
2023
Q4
$207K Sell
1,900
-1,100
-37% -$114K 0.01% 268
2023
Q3
$309K Hold
3,000
0.03% 189
2023
Q2
$346K Sell
3,000
-1,800
-38% -$204K 0.03% 149
2023
Q1
$511K Buy
4,800
+100
+2% +$10.8K 0.04% 132
2022
Q4
$521K Buy
+4,700
New +$480K 0.06% 130
2021
Q1
Sell
-18,864
Closed -$1.47M 467
2020
Q4
$1.47M Buy
+18,864
New +$1.44M 0.08% 123
2019
Q1
Sell
-18,864
Closed -$1.38M 268
2018
Q4
$1.38M Buy
+18,864
New +$1.33M 0.08% 116
2015
Q1
Sell
-182,562
Closed -$9.89M 561
2014
Q4
$9.89M Buy
+182,562
New +$10.2M 0.14% 93

Other funds holding MRK

Marathon Trading Investment Management's MRK Position: Q1 2026 in Review

Marathon Trading Investment Management opened a new position in Merck (MRK) in Q1 2026: 1,921 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #171 among its holdings. This is a return to the name: Marathon Trading Investment Management previously reported a position in MRK as recently as Q3 2025.

Marathon Trading Investment Management first reported a position in MRK in Q4 2014 and has held it in 10 quarters since. The position peaked at $2.63M in Q2 2025. 3,790 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Marathon Trading Investment Management held 1,921 shares of Merck worth $231K as of Q1 2026.
  • Merck was a new Marathon Trading Investment Management position in Q1 2026.
  • Merck made up 0.01% of Marathon Trading Investment Management's portfolio in Q1 2026, its #171 holding.
  • Marathon Trading Investment Management first reported a position in Merck in Q4 2014 and has held it in 10 quarters since.
  • Marathon Trading Investment Management's Merck position peaked at $2.63M in Q2 2025.
  • 3,790 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Marathon Trading Investment Management's 13F filing for Q1 2026, filed 14 May 2026.